Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $5.0300 (-1.76%) ($5.0300 - $5.0300) on Fri. Mar. 26, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 7.82% (three month average) | RSI | 50 | Latest Price | $5.0300(-1.76%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR declines -1.2% a day on average for past five trading days. | Weekly Trend | CAPR declines -2% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) TAN(43%) SIL(27%) SKYY(6%) SLV(5%) XLC(23%) | Factors Impacting CAPR price | CAPR will decline at least -3.91% in a week (0% probabilities). IWD(-52%) LIT(1%) IYT(-26%) IWN(-7%) IWM(-3%) | | | | | Relative Volatility | | | | Market Trend Strength | -3.91% (StdDev 7.82%) | Hourly BBV | 0.3 () | Intraday Trend | 0% | | | |
|
Inflection Point | Yes | Resistance Level | $5.29 | 5 Day Moving Average | $5.13(-1.95%) | 10 Day Moving Average | $5.13(-1.95%) | 20 Day Moving Average | $5.29(-4.91%) | To recent high | -36.6% | To recent low | 0% | Market Cap | $99m | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |